Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways

Considerable emphasis is being placed on combinatorial chemotherapeutic/natural treatments for breast cancer. This study reveals the synergistic anti-tumor activity of morin and Doxorubicin (Dox) co-treatment on MDA-MB-231 triple-negative breast cancer (TNBC) cell proliferation. Morin/Dox treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Maharjan, Sushma, Lee, Min-Gu, Kim, So-Young, Lee, Kyu-Shik, Nam, Kyung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222377/
https://www.ncbi.nlm.nih.gov/pubmed/37242455
http://dx.doi.org/10.3390/ph16050672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222377/
https://www.ncbi.nlm.nih.gov/pubmed/37242455
http://dx.doi.org/10.3390/ph16050672

Ejemplares similares